Evidence map›Paper›PMID 41054241›Full record

ArticleACS applied materials & interfaces2025

Reversibly Cross-Linked Asymmetric Hybrid Open-Polysilsesquioxane Films Enhancing Clotrimazole Bioavailability and Anti-

Marta Madej-Gajewska, Tomasz Janek, Monika Gosecka, Mateusz Gosecki, Malgorzata Urbaniak, Ewelina Wielgus, Łukasz John

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marta Madej-GajewskaFaculty of Chemistry, University of Wrocław, 14 F. Joliot-Curie, Wrocław 50-383, Poland.
Tomasz JanekDepartment of Biotechnology and Food Microbiology, Wrocław University of Environmental and Life Sciences, 37 Chełmonskiego, Wrocław 51-630, Poland.
Monika GoseckaCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, Łódź 90-363, Poland.ORCID 0000-0002-4358-0987
Mateusz GoseckiCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, Łódź 90-363, Poland.ORCID 0000-0002-4901-4687
Malgorzata UrbaniakCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, Łódź 90-363, Poland.
Ewelina WielgusCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, Łódź 90-363, Poland.
Łukasz JohnFaculty of Chemistry, University of Wrocław, 14 F. Joliot-Curie, Wrocław 50-383, Poland.ORCID 0000-0003-1160-2480

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vulvovaginal candidiasis, primarily caused by

Indexed as

Antifungal AgentsBiofilmsCandida albicansCandidiasis, VulvovaginalClotrimazoleOrganosilicon CompoundsBiological AvailabilityDrug CarriersDrug LiberationFemaleHumansMicrobial Sensitivity TestsAntifungal AgentsClotrimazoleDrug CarriersOrganosilicon Compoundspolysilsesquioxaneantifungal intravaginal therapyboronic esterCandida biofilm inhibitioncross-linkable open-POSS cagefilm formulationincompletely condensed POSS cagenetworkswelling ratio

Identifiers

PMID41054241
PMCPMC12532088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.